Nav: Home

ACR sends letter to Congress outlining health care reform priorities

January 18, 2017

ATLANTA - The American College of Rheumatology (ACR) sent a letter to Congressional leaders ahead of actions on health policy, urging lawmakers to adopt a healthcare reform plan that is consistent with the ACR's priority of affordable and accessible healthcare for Americans living with rheumatic diseases.

The ACR stressed in the letter that any proposal should maintain the current ban on insurers excluding coverage due to pre-existing conditions; provide insurance coverage for rheumatic disease specialists and services; maintain coverage of health educational activities for patients with chronic illnesses; limit patient co-payments for specialty drugs and services; and recognize that laboratory, radiological, and infusion services should be conveniently available near the source of a rheumatology patient's medical care.

"More than 52 million people in the U.S. - one in six Americans - live with rheumatic diseases, making it the nation's leading cause of disability," said Dr. Sharad Lakhanpal, MBBS, MD, President of the ACR. "Early and appropriate treatment for rheumatic diseases like arthritis and lupus, provided by trained rheumatologists, can prevent or slow disease progression, decrease the likelihood of disability, and reduce long-term healthcare costs. The ACR looks forward to working with both Congress and the incoming Administration to ensure that every American has access to affordable, high-quality healthcare, including care for arthritis and other rheumatic diseases."

The letter stressed the need to ensure clinical rheumatologists are able to run viable medical practices, noting both the growing scarcity of rheumatologists and the increasing demand for rheumatology care.

"The CDC estimates that one in four Americans will have doctor-diagnosed arthritis by the year 2040," continued Dr. Lakhanpal. "With the rates of doctor-diagnosed arthritis on the rise, a thriving rheumatology workforce and affordable access to specialists and treatments will be critical to ensure we meet the care needs of a growing patient population."

Additionally, the ACR recommended that any reform proposal:
  • Repeals the Independent Payment Advisory Board provision;

  • Minimizes administrate burdens through the use of universal prior authorization systems for multistate health plans; and

  • Maintains the FDA's authority to approve safe, effective biosimilars to encourage market-based relief from the high costs of biologic drugs.

Read the full text of the letter here.
-end-
The American College of Rheumatology (ACR) is the nation's leading advocacy organization for the rheumatology care community, representing more than 6,400 U.S. rheumatologists and rheumatology health professionals. As an ethically driven, professional membership organization committed to improving healthcare for Americans living with rheumatic diseases, the ACR advocates for high-quality, high-value policies and reforms that will ensure safe, effective, affordable and accessible rheumatology care.

American College of Rheumatology

Related Arthritis Articles:

Eating fish may reduce arthritis symptoms
In a recent study, individuals with rheumatoid arthritis who consumed fish 2 times/week had lower disease activity (swollen/tender joint counts along with other assessments) than those who ate fish never to <1/month.
Coping with arthritis: What you do isn't associated with how much information you want
Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Carolina Eshelman School of Pharmacy.
Fish get arthritis, too
The very first bony fish on Earth was susceptible to arthritis, according to a USC-led discovery that may fast-track therapeutic research in preventing or easing the nation's most common cause of disability.
Arthritis linked to suicide attempts
One in every 26 men with arthritis have attempted suicide compared to one in 50 men without arthritis.
Osteoarthritis just as severe as rheumatoid arthritis
Rheumatologists more likely to underestimate clinical status of their OA patients than their RA patients
Blood test that could predict arthritis risk
Testing for antibodies that target citrullinated tenascin-C (cTNC) could diagnose RA in around 50 percent of cases, including some cases not identified by current best tests.
New strategy discovered for treating arthritis
Arthritis patients could one day benefit from a novel form of medicine, according to researchers at Queen Mary University of London.
Arthritis may be a major driver of poverty
Developing arthritis increases the risk of falling into poverty, especially for women, new research shows.
No innocent bystander: Cartilage contributes to arthritis
Melbourne researchers have discovered that cartilage plays an active role in the destruction and remodeling of joints seen in rheumatoid arthritis, rather than being an 'innocent bystander' as previously thought.
Blocking one receptor could halt rheumatoid arthritis
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required.

Related Arthritis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...